We are live on
!
Find out more
ACM
Atlanta Capital Management Portfolio holdings
AUM
$22.5B
1-Year Est. Return
9.67%
This Fund
S&P 500
This Quarter
Est. Return
+2.76%
1 Year Est. Return
-9.67%
3 Year Est. Return
+30.19%
5 Year Est. Return
+88.74%
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$98.4M
(+0.66%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-1.42%
Top 10 Holdings %
Top 10 Hldgs %
22.76%
Holding
164
New
10
Increased
42
Reduced
105
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransUnion
TRU
|
+$125M |
| 2 |
Lennox International
LII
|
+$84.4M |
| 3 |
Fortive
FTV
|
+$59.4M |
| 4 |
Kirby Corp
KEX
|
+$45.8M |
| 5 |
Labcorp
LH
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equifax
EFX
|
+$210M |
| 2 |
Biogen
BIIB
|
+$63M |
| 3 |
Apple
AAPL
|
+$60.7M |
| 4 |
Medtronic
MDT
|
+$44.7M |
| 5 |
West Pharmaceutical
WST
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Industrials | 19.32% |
| 3 | Healthcare | 17.65% |
| 4 | Financials | 17.55% |
| 5 | Consumer Discretionary | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
SLB Ltd
SLB
$75B
| $10.5M | 0.07% |
134,095
-55,038
| -29% | -$4.37M |
|
|
152
Medtronic
MDT
$112B
| $9.58M | 0.06% |
110,876
-512,557
| -82% | -$44.7M |
|
153
EOG Resources
EOG
$70.7B
| $1.76M | 0.01% |
18,234
-778
| -4% | -$68.3K |
|
154
Vanguard Extended Market ETF
VXF
$31.7B
| $937K | 0.01% |
+10,271
| New | +$922K |
|
155
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $582K | ﹤0.01% |
+2,689
| New | +$581K |
|
156
HUB Group
HUBG
$2.92B
| $555K | ﹤0.01% |
27,234
-3,230
| -11% | -$65.7K |
|
157
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
| $277K | ﹤0.01% |
3,837
+94
| +3% | +$6.92K |
|
158
Cognizant
CTSH
$26B
| – | – |
-521,158
| Closed | -$29.8M |
|
159
Hershey
HSY
$36.6B
| – | – |
-2,306
| Closed | -$262K |
|
160
Qualcomm
QCOM
$176B
| – | – |
-601,893
| Closed | -$32.2M |
|
161
Roper Technologies
ROP
$39.8B
| – | – |
-75,216
| Closed | -$12.8M |
|
|
162
West Pharmaceutical
WST
$24.9B
| – | – |
-541,697
| Closed | -$41.1M |
|
|
TYPE
163
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| – | – |
-970,960
| Closed | -$23.9M |
|
|
EMC
164
DELISTED
EMC CORPORATION
EMC
| – | – |
-886,704
| Closed | -$24.1M |
|
Similar funds
JG
AII
MFRM
MA
5L
RC
W
APA
Atlanta Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Atlanta Capital Management held 164 positions worth $15.1B, up 0.66% from $15B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Atlanta Capital Management's Q3 2016 filing shows 10 new, 42 increased, 105 reduced and 7 closed positions. Its largest new stake was TransUnion: 3,718,402 shares worth $128M. The largest sale was Equifax, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.
- Atlanta Capital Management's largest Q3 2016 buy was TransUnion: 3,718,402 shares worth $128M.
- Atlanta Capital Management added most to Kirby Corp in Q3 2016, an estimated $45.8M increase.
- Atlanta Capital Management's biggest Q3 2016 reduction was Equifax, cutting an estimated $210M.
- Atlanta Capital Management fully exited West Pharmaceutical in Q3 2016, selling an estimated $41.1M.
- Atlanta Capital Management's ten largest holdings make up 23% of its $15.1B portfolio in Q3 2016.
- Atlanta Capital Management opened 10 new positions and closed 7 in Q3 2016.
- Atlanta Capital Management's portfolio value rose 0.66% quarter-over-quarter to $15.1B.
Based on Atlanta Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.